OSAM
IBB icon

O'Shaughnessy Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

O'Shaughnessy Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479K Sell
2,517
-741
-23% -$127K ﹤0.01% 1618
2026
Q1 		$550K Buy
3,258
+660
+25% +$113K ﹤0.01% 1492
2025
Q4 		$438K Sell
2,598
-29
-1% -$4.71K ﹤0.01% 1568
2025
Q3 		$379K Buy
2,627
+333
+15% +$45.5K ﹤0.01% 1629
2025
Q2 		$290K Sell
2,294
-409
-15% -$50.2K ﹤0.01% 1653
2025
Q1 		$346K Sell
2,703
-42
-2% -$5.7K ﹤0.01% 1502
2024
Q4 		$363K Buy
2,745
+267
+11% +$37.5K ﹤0.01% 1434
2024
Q3 		$361K Sell
2,478
-1,288
-34% -$186K ﹤0.01% 1379
2024
Q2 		$517K Buy
3,766
+1,780
+90% +$238K 0.01% 1116
2024
Q1 		$273K Buy
1,986
+324
+19% +$44.2K ﹤0.01% 1362
2023
Q4 		$226K Buy
1,662
+217
+15% +$26.5K ﹤0.01% 1353
2023
Q3 		$177K Buy
1,445
+978
+209% +$124K ﹤0.01% 1307
2023
Q2 		$59.3K Buy
467
+19
+4% +$2.47K ﹤0.01% 1338
2023
Q1 		$57.9K Sell
448
-19
-4% -$2.49K ﹤0.01% 1343
2022
Q4 		$61.3K Sell
467
-70
-13% -$9.05K ﹤0.01% 1251
2022
Q3 		$63K Buy
537
+263
+96% +$32.7K ﹤0.01% 1207
2022
Q2 		$32K Buy
274
+19
+7% +$2.25K ﹤0.01% 1176
2022
Q1 		$33K Sell
255
-22
-8% -$2.87K ﹤0.01% 1192
2021
Q4 		$42K Sell
277
-24
-8% -$3.72K ﹤0.01% 1173
2021
Q3 		$49K Buy
301
+24
+9% +$4.04K ﹤0.01% 1652
2021
Q2 		$45K Hold
277
– – ﹤0.01% 1616
2021
Q1 		$42K Hold
277
– – ﹤0.01% 1446
2020
Q4 		$42K Sell
277
-389
-58% -$55.6K ﹤0.01% 1286
2020
Q3 		$90K Buy
666
+411
+161% +$55.8K ﹤0.01% 933
2020
Q2 		$35K Buy
+255
New +$32.5K ﹤0.01% 1056

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

O'Shaughnessy Asset Management's IBB Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 23% in Q2 2026, selling an estimated $127K and leaving 2,517 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

O'Shaughnessy Asset Management first reported a position in IBB in Q2 2020 and has held it in 25 quarters since. The position peaked at $550K in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • O'Shaughnessy Asset Management held 2,517 shares of iShares Biotechnology ETF worth $479K as of Q2 2026.
  • O'Shaughnessy Asset Management sold 741 iShares Biotechnology ETF shares in Q2 2026, an estimated $127K.
  • iShares Biotechnology ETF made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1618 holding.
  • O'Shaughnessy Asset Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 25 quarters since.
  • O'Shaughnessy Asset Management's iShares Biotechnology ETF position peaked at $550K in Q1 2026.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.